Geneva Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $6.98M | Buy |
218,939
+986
| +0.5% | +$31.4K | 0.12% | 107 |
|
|
2017
Q1 | $7.07M | Sell |
217,953
-8,543
| -4% | -$277K | 0.13% | 107 |
|
|
2016
Q4 | $6.98M | Sell |
226,496
-3,605
| -2% | -$111K | 0.14% | 99 |
|
|
2016
Q3 | $7.39M | Buy |
230,101
+18,754
| +9% | +$603K | 0.14% | 102 |
|
|
2016
Q2 | $7.06M | Buy |
211,347
+6,882
| +3% | +$230K | 0.14% | 100 |
|
|
2016
Q1 | $5.75M | Buy |
204,465
+30
| +0% | +$844 | 0.12% | 106 |
|
|
2015
Q4 | $6.26M | Sell |
204,435
-21
| -0% | -$643 | 0.12% | 104 |
|
|
2015
Q3 | $6.09M | Buy |
204,456
+2,200
| +1% | +$65.6K | 0.12% | 108 |
|
|
2015
Q2 | $6.43M | Buy |
202,256
+1,115
| +0.6% | +$35.5K | 0.11% | 114 |
|
|
2015
Q1 | $6.64M | Sell |
201,141
-2,289
| -1% | -$75.6K | 0.12% | 111 |
|
|
2014
Q4 | $6.01M | Sell |
203,430
-10,380
| -5% | -$307K | 0.11% | 113 |
|
|
2014
Q3 | $6M | Buy |
213,810
+6,965
| +3% | +$195K | 0.11% | 117 |
|
|
2014
Q2 | $5.83M | Buy |
206,845
+23,585
| +13% | +$664K | 0.11% | 121 |
|
|
2014
Q1 | $5.59M | Buy |
183,260
+113,066
| +161% | +$3.45M | 0.1% | 114 |
|
|
2013
Q4 | $2.04M | Sell |
70,194
-2,790
| -4% | -$81.1K | 0.04% | 160 |
|
|
2013
Q3 | $1.99M | Buy |
72,984
+12,885
| +21% | +$351K | 0.04% | 167 |
|
|
2013
Q2 | $1.6M | Buy |
+60,099
| New | +$1.6M | 0.04% | 168 |
|